Covis Pharma Group Announces Two Executive Management Team Appointments
January 31, 2022 09:57 ET
|
Covis Pharma
- Michelle Lock Joins Covis Pharma as Chief Operating Officer.- Also Announces Executive Leadership Transition with the Appointment of Sandy Loreaux as President, U.S. Business. ZUG, Switzerland,...
Covis Completes Acquisition of Global Respiratory Portfolio of Two Medicines from AstraZeneca
January 05, 2022 02:30 ET
|
Covis Pharma
ZUG, Switzerland, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Covis Pharma Group (“Covis”), a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening...
Covis Enters Promotion and Distribution Agreement for Two Respiratory Medicines, Seebri® Breezhaler® and Ultibro® Breezhaler®, in Canada
January 05, 2022 02:30 ET
|
Covis Pharma
GUELPH, Ontario, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Covis Pharma Canada Ltd. is pleased to announce that it has entered into an Exclusive Promotion and Distribution Agreement with Novartis...
Covis schließt Übernahme eines globalen Atemwegsportfolios mit zwei Medikamenten von AstraZeneca ab
January 05, 2022 02:30 ET
|
Covis Pharma
ZUG, Schweiz, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Die Covis Pharma Group („Covis“), ein globales spezialisiertes Pharmaunternehmen, das therapeutische Lösungen für Patienten mit lebensbedrohlichen und...
Covis achève l'acquisition du portefeuille de produits respiratoires mondial de deux médicaments auprès d'AstraZeneca
January 05, 2022 02:30 ET
|
Covis Pharma
ZOUG, Suisse, 05 janv. 2022 (GLOBE NEWSWIRE) -- Covis Pharma Group (« Covis »), une société pharmaceutique spécialisée d'envergure internationale qui commercialise des solutions thérapeutiques pour...
Covis Pharma-Gruppe gibt zwei Ernennungen im Managementteam bekannt
December 07, 2021 12:17 ET
|
Covis Pharma
- Ernennung von Raghav Chari zum Chief Innovation Officer, der das Produktportfolio-Lebenszyklusmanagement leiten soll.- Ernennung von Nicolas Verbeke zum Senior Vice President, Europe &...
Covis Pharma Group annonce deux nominations au sein de son équipe de direction
December 07, 2021 12:17 ET
|
Covis Pharma
-Nomination de Raghav Chari au poste de directeur de l'innovation pour diriger la gestion du cycle de vie du portefeuille de produits.-Nomination de Nicolas Verbeke au poste de vice-président...
Covis Pharma Group Announces Two Executive Management Team Appointments
December 07, 2021 01:00 ET
|
Covis Pharma
-Appointment of Raghav Chari as Chief Innovation Officer to lead product portfolio lifecycle management.-Appointment of Nicolas Verbeke as Senior Vice President, Europe & International, to lead...
Covis Significantly Strengthens Global Respiratory Portfolio Through Acquisition of Two Medicines from AstraZeneca
November 01, 2021 03:30 ET
|
Covis Pharma
ZUG, Switzerland, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Covis Pharma Group (“Covis”), a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening...
New data in the European Heart Journal show ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in elderly patients
October 04, 2021 07:00 ET
|
Covis Pharma
ZUG, Switzerland, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Covis Pharma GmbH (“Covis”) and Norgine B.V. (“Norgine”) today announced data demonstrating the investigational anticoagulant reversal agent,...